A study from the University of Pennsylvania reveals that a single dose of psilocybin rapidly and sustainably relieves pain hypersensitivity and anxiodepressive-like behaviors in chronic pain mouse models. The compound acts centrally by normalizing hyperactive pain-processing neurons through serotonin receptor engagement. These findings suggest potential pathways for developing non-opioid, non-addictive therapies addressing comorbid chronic pain and depression.